(lp0
S"Here's Why ImmunoGen, Inc. Skyrocketed 45% in February Motley Fool - Mar 9, 2017 Shares of ImmunoGen , a small-cap biopharmaceutical company that utilizes its proprietary antibody-drug conjugate  technology to fight various forms of cancer, skyrocketed 45% during February, according to data from S&amp;P Global&nbsp;...The 4.5% Stake of ImmunoGen, Inc.  Owned by Primecap Management Company - DailyQuintImmunoGen, Inc.  Cut to Hold at Zacks Investment Research - BBNS"
p1
aS"Why ImmunoGen, Inc. Skyrocketed Higher Today Motley Fool - Feb 27, 2017 It's also possible investors are buying ahead of the Society of Gynecologic Oncology's Annual Meeting of Women's Cancer next month where ImmunoGen is scheduled to present additional phase 1 data from a subset of patients getting its cancer medication&nbsp;...ImmunoGen Inc  Has A Wave Of Catalysts About To Hit Press - Insider FinancialImmunoGen, Inc.  Update On Trial of Mirvetuximab Soravtansine - Journal Transcript"
p2
aS"3 Charts That Show the Potential Risks and Rewards for Immunogen, Inc. Stock Motley Fool - Mar 4, 2017 After 36 years of being in business, Immunogen  has yet to make a profit. Unfortunately, the biotech still isn't close to reaching break-even status."
p3
aS"Why Analysts put forward these two stocks: ImmunoGen, Inc. , Rice Energy ... The USA Commerce - 19 hours ago Shares of ImmunoGen, Inc.  surged 1.57% to $3.88. During the trading on 03/14/2017, Company's stock ranged from $3.77 to $4.06.ImmunoGen Inc.  Moves Higher on Volume Spike for March 14 - Equities.comImmunoGen, Inc.  Given Hold Rating at Cowen and Company - Chaffey Breeze"
p4
aS"Option Market: ImmunoGen Inc Risk Hits An Unsually High Level CML News - 18 hours ago We're going to look at a proprietary risk rating for the next 30-days built by Capital Market Laboratories  based on a large number of interactions of data points, many of which come directly from the option market for ImmunoGen Inc  ."
p5
aS'ImmunoGen Inc.  Moves Higher on Volume Spike for March 10 Equities.com - Mar 10, 2017 ImmunoGen Inc.  traded on unusually high volume on Mar. 10, as the stock gained 1.91% to close at $3.73. On the day, ImmunoGen Inc. saw 4.78 million shares trade hands on 14,569 trades. Considering that the stock averages only a daily volume of&nbsp;...ImmunoGen, Inc.  Receives Consensus Rating of Hold from Analysts - Chaffey BreezeThe ImmunoGen, Inc.  Downgraded by Zacks Investment Research to Hold - DailyQuint'
p6
aS"ImmunoGen Inc  Runs Higher 17.22% For the Week Business Review - 19 hours ago Shares of ImmunoGen Inc  have seen strong upward momentum over the past week as they have moved higher 17.22% over the past five sessions, placing them on this week's winners list."
p7
aS'Stock Returns: BioCryst Pharmaceuticals Inc  versus ImmunoGen Inc ... CML News - Mar 14, 2017 This is a snapshot to compare the stock returns for BioCryst Pharmaceuticals Inc  versus ImmunoGen Inc  .Healthcare Stocks Flagged As Top Movers: BioCryst Pharmaceuticals, Inc. (BCRX ... - TWNBiotech stocks for your portfolio: BioCryst Pharmaceuticals, Inc. (BCRX ... - The Independent Republic'
p8
aS'Immunogen Inc.  PT Lowered to $1.30 at Morgan Stanley StreetInsider.com - Mar 1, 2017 Morgan Stanley lowered its price target on Immunogen Inc.  to $1.30  while maintaining a Underweight rating.ImmunoGen, Inc.  Lowered to Hold at Zacks Investment Research - The Cerbat Gem'
p9
aS'ImmunoGen Inc.  Soars 6.08% on March 02 Equities.com - Mar 2, 2017 ImmunoGen Inc.  had a good day on the market for Thursday March 02 as shares jumped 6.08% to close at $3.58. About 5.06 million shares traded hands on 17,783 trades for the day, compared with an average daily volume of 1.9 million shares out of&nbsp;...'
p10
a.